β-talasemia intermedia i minor
Leczenie podtrzymujące
Chelatacja żelaza
Iron out for nontransfused thalassemia. (opens new window)
Źródło: Blood 2012;120(5):928-9.
Indeks: PubMed 22859709
DOI: 10.1182/blood-2012-06-433227
https://www.ncbi.nlm.nih.gov/pubmed/22859709 (opens new window)
Iron overload in β-thalassemia intermedia: an emerging concern. (opens new window)
Źródło: Curr Opin Hematol 2013;20(3):187-92.
Indeks: PubMed 23426199
DOI: 10.1097/MOH.0b013e32835f5a5c
https://www.ncbi.nlm.nih.gov/pubmed/23426199 (opens new window)
Suplementy diety i inne terapie podtrzymujące
Treatment with bosentan in a patient with thalassemia intermedia and pulmonary arterial hypertension. (opens new window)
Źródło: Blood 2012;120(7):1531-2.
Indeks: PubMed 22899478
DOI: 10.1182/blood-2012-04-422568
https://www.ncbi.nlm.nih.gov/pubmed/22899478 (opens new window)
Prevalance of iron deficiency in thalassemia minor: a study from tertiary hospital. (opens new window)
Źródło: Indian J Hematol Blood Transfus 2012;28(1):7-9.
Indeks: PubMed 23449336
DOI: 10.1007/s12288-011-0088-9
https://www.ncbi.nlm.nih.gov/pubmed/23449336 (opens new window)
Therapeutic roles of curcumin: lessons learned from clinical trials. (opens new window)
Źródło: AAPS J 2013;15(1):195-218.
Indeks: PubMed 23143785
DOI: 10.1208/s12248-012-9432-8
https://www.ncbi.nlm.nih.gov/pubmed/23143785 (opens new window)
Vitamin E supplement improves erythrocyte membrane fluidity of thalassemia: an ESR spin labeling study. (opens new window)
Źródło: J Med Assoc Thai 2012;95(1):29-36.
Indeks: PubMed 22379738
https://www.ncbi.nlm.nih.gov/pubmed/22379738 (opens new window)
Deferasirox demonstrates a dose-dependent reduction in liver iron concentration and consistent efficacy across subgroups of non-transfusion-dependent thalassemia patients. (opens new window)
Źródło: Am J Hematol 2013;88(6):503-6.
Indeks: PubMed 23553596
DOI: 10.1002/ajh.23445
https://www.ncbi.nlm.nih.gov/pubmed/23553596 (opens new window)